Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
145.68
-3.18 (-2.14%)
At close: Aug 28, 2026, 4:00 PM EDT
139.30
-6.38 (-4.38%)
After-hours: Aug 28, 2026, 7:46 PM EDT
Gilead Sciences Stock Forecast
Stock Price Forecast
According to 29 analysts polled by S&P Global, Gilead Sciences stock has a consensus rating of "Buy" and an average price target of $157.41. The average 1-year stock price forecast is 8.05% higher than the current stock price, while the lowest is $123 (-15.57%) and the highest is $180 (+23.56%).
Price Target: $157.41 (+8.05%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Gilead Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 18 | 18 | 18 | 16 | 16 | 16 |
| Buy | 5 | 5 | 6 | 6 | 6 | 6 |
| Hold | 8 | 8 | 7 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 31 | 31 | 31 | 29 | 29 | 29 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Maintains $174 | Buy | Maintains | $174 | +19.44% | Aug 28, 2026 |
| Scotiabank | Scotiabank | Buy Maintains $177 | Buy | Maintains | $177 | +21.50% | Aug 28, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 28, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $165 | Buy | Maintains | $165 | +13.26% | Aug 21, 2026 |
| Barclays | Barclays | Hold Maintains $145 | Hold | Maintains | $145 | -0.47% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
30.69B
from 29.44B
Increased by 4.24%
Revenue Next Year
32.70B
from 30.69B
Increased by 6.52%
EPS This Year
-0.42
from 8.15
EPS Next Year
9.89
from -0.42
EPS and Forward PE are based on non-GAAP adjusted numbers.